| Gujarat Kidney & Super Speciality Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 544666 |
NSE Symbol : GKSL |
P/E(TTM) : 107.02 |
|
ISIN Demat : INE0V0W01025 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.26 |
|
Book Value(₹) : 31.26 |
Market Cap(₹Cr) : 1,063.20 |
Face Value(₹) : 2.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 9.24 | 9.76 | 9.64 | 11.45 | 8.02 | 8.51 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 9.24 | 9.76 | 9.64 | 11.45 | 8.02 | 8.51 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.45 | 0.03 | 0.02 | 0.00 | 0.04 | 0.02 |
| Total Income | 9.69 | 9.79 | 9.66 | 11.45 | 8.06 | 8.53 |
| Total Expenditure | 7.67 | 5.62 | 5.55 | 5.12 | 5.71 | 4.70 |
| PBIDT | 2.03 | 4.17 | 4.11 | 6.33 | 2.35 | 3.83 |
| Interest | 0.50 | 0.29 | 0.23 | 0.13 | 0.12 | 0.11 |
| PBDT | 1.53 | 3.88 | 3.88 | 6.20 | 2.23 | 3.72 |
| Depreciation | 0.67 | 0.72 | 0.75 | 0.80 | 0.75 | 0.66 |
| Tax | -0.10 | 0.86 | 0.86 | 1.55 | 0.39 | 1.02 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.41 | -0.03 | -0.04 | -0.05 | -0.18 | -0.17 |
| Reported Profit After Tax | 1.37 | 2.33 | 2.30 | 3.90 | 1.26 | 2.21 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.37 | 2.33 | 2.30 | 3.90 | 1.26 | 2.21 |
| EPS (Unit Curr.) | 0.22 | 0.41 | 0.40 | 0.69 | 0.25 | 0.46 |
| EPS (Adj) (Unit Curr.) | 0.22 | 0.41 | 0.40 | 0.69 | 0.25 | 0.46 |
| Calculated EPS (Unit Curr.) | 0.17 | 0.41 | 0.40 | 0.69 | 0.22 | 0.39 |
| Calculated EPS (Adj) (Unit Curr.) | 0.17 | 0.41 | 0.40 | 0.69 | 0.22 | 0.39 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.69 | 1.64 | 1.62 | 2.74 | 0.89 | 1.56 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.69 | 1.64 | 1.62 | 2.74 | 0.89 | 1.56 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 15.77 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 21.97 | 42.73 | 42.63 | 55.28 | 29.30 | 45.01 |
| PBDTM(%) | 16.56 | 39.75 | 40.25 | 54.15 | 27.81 | 43.71 |
| PATM(%) | 14.83 | 23.87 | 23.86 | 34.06 | 15.71 | 25.97 |
